GlucoTrack, Inc. (GCTK)
NASDAQ: GCTK · Real-Time Price · USD
6.00
+0.02 (0.33%)
At close: Dec 5, 2025, 4:00 PM EST
5.96
-0.04 (-0.67%)
After-hours: Dec 5, 2025, 6:51 PM EST
GlucoTrack Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
11
Market Cap
5.46M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | 208.00K | 164.51K | 378.29% |
| Dec 31, 2018 | 43.49K | -545.97K | -92.62% |
| Dec 31, 2017 | 589.46K | -22.23K | -3.63% |
| Dec 31, 2016 | 611.69K | 468.52K | 327.26% |
| Dec 31, 2015 | 143.17K | 83.39K | 139.51% |
| Dec 31, 2014 | 59.78K | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
GCTK News
- 23 days ago - Glucotrack Reports Third Quarter 2025 Financial Results and Provides Update on Recent Corporate Highlights - GlobeNewsWire
- 4 weeks ago - Glucotrack, Inc. Encourages Shareholders to Vote - GlobeNewsWire
- 5 weeks ago - Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team - GlobeNewsWire
- 5 weeks ago - Glucotrack, Inc. Reminds Shareholders to Vote - GlobeNewsWire
- 3 months ago - Glucotrack to Participate in the Q3 Virtual Investor Summit - GlobeNewsWire
- 4 months ago - Glucotrack Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 4 months ago - Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology - GlobeNewsWire
- 4 months ago - Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting - GlobeNewsWire